Highlights and Quick Summary
- Income from Continuous Operations for the quarter ending December 31, 2022 was $-26.8 Million (a 250.9% increase compared to previous quarter)
- Year-over-year quarterly Income from Continuous Operations increased by 39.33%
- Annual Income from Continuous Operations for 2022 was $-79.8 Million (a -28.0% decrease from previous year)
- Annual Income from Continuous Operations for 2021 was $-111 Million (a 6.09% increase from previous year)
- Annual Income from Continuous Operations for 2020 was $-104 Million (a -38.68% decrease from previous year)
- Twelve month Income from Continuous Operations ending December 31, 2022 was $-79.8 Million (a -5.77% decrease compared to previous quarter)
- Twelve month trailing Income from Continuous Operations decreased by -26.28% year-over-year
Trailing Income from Continuous Operations for the last four month:
31 Dec '22 | 30 Sep '22 | 30 Jun '22 | 31 Mar '22 |
---|---|---|---|
$-79.8 Million | $-84.7 Million | $-103 Million | $-108 Million |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Income from Continuous Operations of Precigen, Inc.
Most recent Income from Continuous Operationsof PGEN including historical data for past 10 years.Interactive Chart of Income from Continuous Operations of Precigen, Inc.
Precigen, Inc. Income from Continuous Operations for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | $-26.82 | $-7.64 | $-26.06 | $-19.25 | $-79.78 |
2021 | $-31.71 | $-26.32 | $-30.94 | $-21.84 | $-110.81 |
2020 | $-40.35 | $-27.54 | $-15.71 | $-20.85 | $-104.44 |
2019 | $-36.08 | $-49.05 | $-32.31 | $-52.9 | $-170.33 |
2018 | $-207.5 | $-58.75 | $-66.83 | $-47.41 | $-380.49 |
2017 | $12.44 | $-40.84 | $-19.66 | $-32.38 | $-80.44 |
2016 | $-44.91 | $-30.01 | $-50.03 | $-65.32 | $-190.27 |
2015 | $-33.28 | $-39.03 | $-41.49 | $25.8 | $-87.99 |
2014 | $17.93 | $-53.86 | $-52.94 | $3.25 | $-85.62 |
2013 | $-13.02 | $14.99 | $-6.52 | $-36.36 | $-40.91 |
2012 | $-20.49 | $-16.54 | – | – | $-81.87 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology